As of Oct 26, 2026: Inovio Pharmaceuticals (INO) has a PDUFA date for INO-3107 on Oct 30, 2026, in 4 days. Scores as of 5:17 PM ET, 15 minutes behind.

INO FDA decision on INO-3107

Inovio Pharmaceuticals · PDUFA date

PDUFA dateOct 30in 4 days

Quality Score–not scored

Cash runway1quarter of cash

What the company said

“License Application (BLA) for INO-3107 as a treatment for Recurrent Respiratory Papillomatosis (RRP) advancing with a target Prescription Drug User Fee Act (PDUFA) date of October 30, 2026”

PDUFA date, Oct 30, 2026. As Inovio Pharmaceuticals stated in its 8-K of Aug 12, 2026 (the filing).

A PDUFA date is the day the FDA has said it aims to decide on a drug. The FDA can decide earlier, or extend its review, often by three months.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Get an alert before INO's FDA date

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

How INO's stock moved on its past FDA days, for Pro members. Pro members also see whether its cash lasts past Oct 30, and the members' FDA calendar with filters and optional alerts.

More on INO and the FDA calendar

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

The FDA calendar.